Cover Image

Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis

Quality of life impairment in dermatology patients and severity of psoriasis are quantified by the Dermatology Life Quality Index (DLQI) and the Psoriasis Area and Severity Index (PASI), respectively. The aim of this study is to compare the correlation between PASI and DLQI in patients from differen...

Full description

Saved in:

Bibliographic Details
Main Authors:	Julia-Tatjana Maul (Author), Lara W. Maul (Author), Johannes A. Didaskalu (Author), Fernando Valenzuela (Author), Ricardo Romiti (Author), Hannah Peterson (Author), Edwin Korouri (Author), Farah Novoa (Author), Hazel H. Oon (Author), Min Zheng (Author), Jashin J. Wu (Author), Jacob P. Thyssen (Author), Alexander Egeberg (Author), April W. Armstrong (Author), Mia-Louise Nielsen (Author)
Format:	Book
Published:	Medical Journals Sweden, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mapping the road to biologics in psoriasis and psoriatic arthritis: A nationwide drug utilization study
by: David Thein, et al.
Published: (2023)

Predicting discontinuation of biologic therapy caused by adverse events in psoriasis patients-A Danish nationwide cohort study
by: Mia‐Louise Nielsen, et al.
Published: (2023)

The impact of gender and sex in psoriasis: What to be aware of when treating women with psoriasis
by: Carole Guillet, MD, et al.
Published: (2022)

Correlation Between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis Treated with Ustekinumab
by: Jeanette Halskou Hesselvig, et al.
Published: (2017)

Correlation of Psoriasis Disability Index and Psoriasis Area and Severity Index: A Study from Afghanistan
by: Aalemi AK, et al.
Published: (2022)

Translation and validation of the Simplified Psoriasis Index (SPI) into Brazilian Portuguese
by: Marina Resener de Morais, et al.
Published: (2018)

PASI (Psoriasis Area and Severity Index) in the evaluation of the clinical manifestations of psoriasis
by: A. A. Kubanov, et al.
Published: (2017)

Beauty and the Biologic: Artistic Documentation of Scientific Breakthrough in Psoriasis
by: Julia-Tatjana Maul, et al.
Published: (2015)

Incidence and Prevalence of Psoriasis in Denmark
by: Alexander Egeberg, et al.
Published: (2017)

Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States
by: April W. Armstrong, et al.
Published: (2023)

Psoriasis and Co-morbidity
by: Mina Amin, et al.
Published: (2020)

Associations between body mass index and severity of psoriasis
by: Sobhan M, et al.
Published: (2017)

Validation of Psoriasis Diagnoses in the Danish National Patient Register
by: Nikolai Dyrberg Loft, et al.
Published: (2019)

Psoriasis: correlation between severity index (PASI) and systemic treatment
by: Maria Flavia Pereira da Silva, et al.
Published: (2013)

Is Clear Always Clear? Comparison of Psoriasis Area and Severity Index (PASI) and the Physician's Global Assessment (PGA) in Psoriasis Clearance
by: Albert G. Wu, et al.
Published: (2020)

Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)
by: Andreas Pinter, et al.
Published: (2024)

Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey of Adults with Psoriasis in the United States
by: Teri Greiling, et al.
Published: (2024)

Study of Nail Psoriasis and Dermoscopic Correlation With Dermoscopic and Modified Dermoscopic Nail Psoriasis Severity Indexes (dNAPSI and dmNAPSI)
by: Sandeep Arora, et al.
Published: (2022)

[Translated article] Translation into Spanish and Field-Testing of a New Score for Evaluating Psoriasis Severity: The Simplified Psoriasis Index (SPI)
by: D. Barquero-Orias, et al.
Published: (2022)

Risk of Myocardial Infarction in Patients with Psoriasis and Psoriatic Arthritis: A Nationwide Cohort Study
by: Alexander Egeberg, et al.
Published: (2017)

Guselkumab in Patients with Scalp Psoriasis: A post hoc Analysis of the VOYAGE 2 Phase III Randomized Clinical Trial
by: Enikö Sonkoly, et al.
Published: (2024)

Interobserver variation of psoriasis area and severity index in a clinical setting
by: Neema Sandra Dias, et al.
Published: (2020)

Suprabasal mitotic index: A cell kinetic aid in psoriasis diagnosis
by: Susan Maria Mendonca, et al.
Published: (2017)

Interobserver variation of psoriasis area and severity index in a clinical setting
by: Neema Sandra Dias, et al.
Published: (2020)

Tildrakizumab Treatment for Psoriasis in Real-world Practice: An Analysis from the Swiss Registry (SDNTT)
by: Julia-Tatjana Maul, et al.
Published: (2024)

Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort
by: Marloes E. van Muijen, et al.
Published: (2022)

Telemedicine and psoriasis: A review based on statements of the telemedicine working group of the International Psoriasis Council
by: Mohamed H. M. El Komy, et al.
Published: (2023)

Evidence and suggested therapeutic approach in psoriasis of difficult-to-treat areas: Palmoplantar psoriasis, nail psoriasis, scalp psoriasis, and intertriginous psoriasis
by: Nilendu Sarma
Published: (2017)

Clinical Goals and Barriers to Effective Psoriasis Care
by: Bruce E. Strober, et al.
Published: (2018)

Bounded integer model‐based analysis of psoriasis area and severity index in patients with moderate‐to‐severe plaque psoriasis receiving BI 730357
by: Qing Xi Ooi, et al.
Published: (2023)

Psoriasis: Correlation between severity index (PASI) and quality of life index (DLQI) based on the type of treatment
by: Ali Al Raddadi, et al.
Published: (2016)

Treatment burden and the perspectives of patients with psoriasis using topical treatments: results from a national survey of adults with psoriasis in the United States
by: April Armstrong, et al.
Published: (2024)

Generalized pustular psoriasis (von Zumbusch)
by: Ricardo Romiti, et al.
Published: (2022)

Association of leptin, resistin, and high-molecular-weight adiponectin levels with psoriasis area and severity index scores, obesity, and insulin resistance in psoriasis patients
by: Emine Müge Acar, et al.
Published: (2019)

The Relationship between Tissue Thioredoxin Reductase Activity and the Psoriasis Area and Severity Index
by: Bita Kiafar, et al.
Published: (2020)

Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO)
by: Travaglini M, et al.
Published: (2023)

Psoriasis coxsackium
by: Daniel W. Cole, MD, et al.
Published: (2022)

Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA)
by: Kristian Reich, et al.
Published: (2024)

Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40
by: Richard G. Langley, MD, et al.
Published: (2024)

Psoriasis herpeticum: Kaposi's varicelliform eruption in psoriasis
by: Yu-Ting Yeh
Published: (2015)